Atlas Trials

Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer

Clinical trial NCT03081494 · COMPLETED

Trial details

NCT number
NCT03081494
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2017-06-09
Primary completion
2019-05-07
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.